The present invention is drawn to set of formulations of at least one compound selected from tolterodine, salts thereof, prodrugs thereof and / or metabolites thereof, wherein in the set of formulations contains at least one device for transdermal administration and at least one formulation for oral, sublingual, buccal, nasal, pulmonary, rectal and / or other transmucosal administration, in order to achieve an effect against overactive bladder and / or symptoms associated with this condition. The present invention is further drawn to methods of treating an overactive bladder with the formulations.